Childress Capital Advisors »

United Therapeutics Corporation shares owned by Childress Capital Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Childress Capital Advisors from 13F filings

Historical chart of Childress Capital Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Childress Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Childress Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $283k 580 487.25

More positions owned by Childress Capital Advisors

Fidelity Covington Trust High Divid Etf (FDVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Goldman Sachs (GS)
Exxon Mobil Corporation (XOM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Main Street Capital Corporation (MAIN)
Microsoft Corporation (MSFT)
ConocoPhillips (COP)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
Alphabet Cap Stk Cl A (GOOGL)
Energy Transfer Com Ut Ltd Ptn (ET)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)

View all positions for Childress Capital Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation